Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : $2 or higher gas - Can ethanol make a comeback? -- Ignore unavailable to you. Want to Upgrade?

To: Lance Bredvold who wrote (2781)	5/20/2016 9:39:44 AM
From: richardred	Read Replies (1) \| Respond to of 2801

RE; ARTW I made out very well as I sold my first position during the ethanol boom, before it went bust. Not working out to well this time. The stock had a quick run again a couple years ago. This when it was thought the Ebola scare would lead to orders for Artway Scientific. It just never happened. I myself really thought some of the leading research hospitals might come through for some orders for future preparedness. It also made sense to me that countries affected or subject to Ebola, to have facilities to work in for containment. For cash & economically poor countries. The funding I thought, by organizations that support the World Health Organization. Aside from that miss, the farming side, and scientific side of buildings IMO still have potential. The rest of the diverse business (Vessels & machine tools)is a drag to mixed bag for now I think. For the farming side. This might not be any bellwether sign, but I think Deere just reported ok results for this qtr. Moving forward I just guess it just depends on how well Artway dealer/distributors want to replenish or stock inventory levels? P.S. Message 23705201

To: Lance Bredvold who wrote (2781)	8/2/2016 6:55:48 PM
From: richardred	Respond to of 2801

Lance ARTW a loss of a penny on a big sales decline. FWIW-I guess I have to be impressed with that. This in regards how they must have brought the cost structure down. If and when they ever get selling. IMO Margins should be a lot better than before. Ebola never lead to scientific orders. But hey, just maybe money to be spent on Zika virus related is a remote possibility for scientific?